| Title |
Trimethoprim–sulfamethoxazole and risk of sudden death among patients taking spironolactone
|
|---|---|
| Published in |
Canadian Medical Association Journal, February 2015
|
| DOI | 10.1503/cmaj.140816 |
| Pubmed ID | |
| Authors |
Tony Antoniou, Simon Hollands, Erin M. Macdonald, Tara Gomes, Muhammad M. Mamdani, David N. Juurlink |
| Abstract |
Trimethoprim-sulfamethoxazole increases the risk of hyperkalemia when used with spironolactone. We examined whether this drug combination is associated with an increased risk of sudden death, a consequence of severe hyperkalemia. |
X Demographics
The data shown below were collected from the profiles of 247 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 33 | 13% |
| United States | 21 | 9% |
| Canada | 19 | 8% |
| United Kingdom | 16 | 6% |
| Japan | 8 | 3% |
| Venezuela, Bolivarian Republic of | 3 | 1% |
| Saudi Arabia | 3 | 1% |
| Argentina | 2 | <1% |
| Peru | 1 | <1% |
| Other | 13 | 5% |
| Unknown | 128 | 52% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 187 | 76% |
| Practitioners (doctors, other healthcare professionals) | 45 | 18% |
| Scientists | 13 | 5% |
| Science communicators (journalists, bloggers, editors) | 2 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 1% |
| Japan | 1 | 1% |
| Unknown | 84 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 14 | 16% |
| Researcher | 9 | 10% |
| Student > Master | 9 | 10% |
| Student > Bachelor | 8 | 9% |
| Student > Ph. D. Student | 7 | 8% |
| Other | 18 | 21% |
| Unknown | 21 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 37 | 43% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 13% |
| Nursing and Health Professions | 6 | 7% |
| Biochemistry, Genetics and Molecular Biology | 3 | 3% |
| Agricultural and Biological Sciences | 3 | 3% |
| Other | 4 | 5% |
| Unknown | 22 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 278. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 April 2023.
All research outputs
#130,925
of 25,758,695 outputs
Outputs from Canadian Medical Association Journal
#243
of 9,546 outputs
Outputs of similar age
#1,438
of 362,380 outputs
Outputs of similar age from Canadian Medical Association Journal
#3
of 108 outputs
Altmetric has tracked 25,758,695 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,546 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.3. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,380 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 108 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.